Etodesnitazepipne

Etodesnitazepipne

Molecular structure via molpic based on CDK

Rotamer []

Conformer structure via 3Dmol.js

Physical properties []
Molecular mass	363.5 g/mol ^[1]
Predicted LogP	4.6 ^[1]

Structural Identifiers []
Molecular formula	C₂₃H₂₉N₃O ^[1]
IUPAC name	2-[(4-ethoxyphenyl)methyl]-1-(2-piperidin-1-ylethyl)benzimidazole ^[1]
SMILES	CCOC1=CC=C(C=C1)CC2=NC3=CC=CC=C3N2CCN4CCCCC4 ^[1]
InChI	InChI=1S/C23H29N3O/c1-2-27-20-12-10-19(11-13-20)18-23-24-21-8-4-5-9-22(21)26(23)17-16-25-14-6-3-7-15-25/h4-5,8-13H,2-3,6-7,14-18H2,1H3 ^[1]
InChIKey	YRQHBFGBBWMQNH-UHFFFAOYSA-N ^[1]

Etodesnitazepipne (also known as 1H-Benzimidazole, 2-((4-ethoxyphenyl)methyl)-1-(2-(1-piperidinyl)ethyl)- or 2-((4-Ethoxyphenyl)methyl)-1-(2-(1-piperidinyl)ethyl)-1H-benzimidazole) is a opioid substance of the nitazepipne class.

Chemistry

Stereochemistry []

Etodesnitazepipne is a achiral mixture.

Subjective effects []

class / Opioid

Physical effects
Constipation Cough suppression Difficulty urinating Itchiness Nausea Pain relief Pupil constriction Respiratory depression Sedation Stomach cramp

Cognitive effects
Anxiety suppression Cognitive euphoria Compulsive redosing Increased music appreciation Thought deceleration

Visual effects
Double vision

External links []

References []

National Center for Biotechnology Information. PubChem Compound Summary for CID 162623611, Etodesnitazepipne. Accessed June 7, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/162623611
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Etodesnitazepipne. UNII: 5A4W2D7JM6. Global Substance Registration System. Accessed June 7, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/5A4W2D7JM6

AnodyneWiki